GOOD Meat

ApplicationAlameda, California, USAFounded 2011· One of 686 Application companies tracked by AMPulse

Produces cultivated meat using bioprinting and cellular agriculture technology, creating real animal meat from cells without slaughtering animals.

CEO / Founder: Josh Tetrick
Team Size: 201-500
Stage: Active
Total Funding: $267M
Latest Round: Corporate Round
Key Investors: GTCC Wealth; One One Five Group of Companies; Bill Gates; Marc Benioff; Qatar Investment Authority; U.S. Department of Agriculture; C2 Capital; Qatar Free Zones Authority

Technology & Products

Key Products

Cultivated meat (chicken, beef); JUST Egg (plant-based egg substitute)

Technological Advantage

First-mover advantage with regulatory approvals in Singapore and the U.S.; proprietary cell culture and bioprinting technology for scalable meat production

Differentiation

Value Proposition

Provides real meat without environmental impact or animal slaughter, offering a sustainable alternative with identical taste and texture to conventional meat.

How They Differentiate

First-to-market with regulatory approvals; focuses on cultivated meat rather than plant-based alternatives; uses bioprinting for structured meat products

Market & Competition

Target Customers

Restaurants, retailers, and consumers seeking sustainable and ethical meat alternatives

Industry Verticals

Food and Beverage; Biotechnology; Sustainable Agriculture

Competitors

Upside Foods; Believer Meats; Mosa Meat

Growth & Milestones

Growth Metrics

First cultivated meat company to receive U.S. FDA clearance; products sold in Singapore and U.S. restaurants

Major Milestones

First regulatory approval in Singapore (2020); U.S. FDA clearance (2023); First U.S. restaurant service at China Chilcano (2023); First retail sales at Huber's Butchery

Notable Customers

China Chilcano by José Andrés; Huber's Butchery

https://www.goodmeat.co

AM patents

AM-relevant patents linked to this company.

Patents: 1
Granted: 0
Families: 1

Leading domains: process (1)

Filings by year: 2021: 1

EXTRUDATE FOOD COMPOSITIONS COMPRISING CULTIVATED ANIMAL CELLS AND METHODS OF PRODUCTION THEREOF20220079194 · US2022-03-17

Funding rounds

Grant$267M2023Source: GOOD Meat website
Corporate Round$25M2023Source: GOOD Meat website
Venture Round$200M2021-03Lead: Qatar Investment Authority · Source: TechCrunch

Why this company matters

AMPulse analysis, not a company disclosure

GOOD Meat, a division of Eat Just, occupies a distinctive position as the world's first company to receive regulatory approval to sell cultivated meat. Founded in 2011 and based in San Francisco, the company addresses the environmental and ethical costs of conventional animal agriculture by growing meat directly from animal cells, bypassing the need for raising and slaughtering livestock. Its product line includes cultivated chicken and beef, alongside the plant-based JUST Egg brand, which provides a separate revenue stream in the alternative protein market.

The core technology combines cellular agriculture with bioprinting, specifically material extrusion (MEX) methods, to produce structured meat products. GOOD Meat's proprietary cell culture and bioprinting processes aim to replicate the texture and taste of conventional meat at scale. The company holds multiple patents covering bioprinting methods for cultivated meat production, including scaffold-free three-dimensional bioprinting techniques.

GOOD Meat targets restaurants, retailers, and consumers seeking sustainable and ethical meat alternatives. Notable early customers include China Chilcano by José Andrés in Washington, D.C., and Huber's Butchery in Singapore, where the product first launched. The company has secured regulatory clearances in Singapore (2020) and from the U.S. FDA (2023), giving it a first-mover advantage over competitors like Upside Foods, Believer Meats, and Mosa Meat.

Key partnerships with ADM and ABEC support production scale-up, while investors including Bill Gates, Marc Benioff, and the Qatar Investment Authority have contributed to $1.21 billion in total funding. A critical open question is whether GOOD Meat can reduce production costs to price parity with conventional meat and achieve the manufacturing volumes needed for widespread retail distribution.